Bepotastin

Bepotastin
(IUPAC) ime
	4-[4-[(4-hlorofenil)-piridin-2-ilmetoksi]piperidin-1-il]butanoinska kiselina
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
MedlinePlus	a610012
Identifikatori
CAS broj	125602-71-3
ATC kod	nije dodeljen
PubChem	2350
DrugBank	DB04890
ChemSpider	2260
UNII	HYD2U48IAS
KEGG	D09705
ChEMBL	CHEMBL1201758
Hemijski podaci
Formula	C21H25ClN2O3
Mol. masa	388,88 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C21H25ClN2O3/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26) ; Key: YWGDOWXRIALTES-UHFFFAOYSA-N
Farmakokinetički podaci
Bioraspoloživost	Visoka (oralno); Minimalna (topikalno)
Vezivanje za proteine plazme	~55%
Izlučivanje	Renalno (75–90%)
Farmakoinformacioni podaci
Trudnoća	C(US)
Pravni status	℞ Prescription only
Način primene	Oralno, topikalno (kapi za oči)

Bepotastin (Talion) je antihistaminik.^[6] On je odobren u Japanu za upotrebu u tretmanu alergijskog rinitisa i urtikarija/pruritusa u julu 2000. i januaru 2002, respektivno. Na tržište ga je izvela kompanija Tanabe Seiyaku Co., Ltd. pod imenom Talion. Tanabe Seiyaku je odobrila kompaniji Senju ekskluzvna globalna prava, izuzev pojedinih Azijskih zemalja, za razvoj, proizvodnju, i prodaju za oftalmičku upotrebu.

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ H. Takahashi, A. Ishida-Yamamoto, H. Iizuka (September 2004). „Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance”. Clinical and Experimental Dermatology 29: 526–532. DOI:10.1111/j.1365-2230.2004.01618.x.

Spoljašnje veze

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] H. Takahashi, A. Ishida-Yamamoto, H. Iizuka (September 2004). „Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance”. Clinical and Experimental Dermatology 29: 526–532. DOI:10.1111/j.1365-2230.2004.01618.x.

[1]

[2]

[3]

[4]

[5]

[6]